Key Insights

Highlights

Treatment Research

3 treatments under study, led by Early Transcatheter Edgetoedge Mitral Valve Repair Teer

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06282042Not ApplicableRecruitingPrimary

Early Transcatheter Mitral Valve Repair After Myocardial Infarction

Showing all 1 trials

Research Network

Common Treatments

  • Early Transcatheter Edgetoedge Mitral Valve Repair Teer1
  • Mitraclip1
  • Optimal Medical Treatment1

Active Sponsors

  • Meditrial Europe Ltd.1
  • Fundación para la Investigación Biosanitaria del Principado de Asturias1

Top Investigators

Activity Timeline